Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Smith

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Blood Advances|March 19, 2026
Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin LymphomaGrace Baek, Gaurav Varma, Samuel Yamshon, et al.
British Journal of Haematology|December 22, 2018
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphomaBrian T Hill, Loretta Nastoupil, Allison M Winter, et al.
Frontiers in Oncology|May 19, 2023
A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trialsJeffrey R Whiteaker, Lei Zhao, Regine M Schoenherr, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, et al.
Haematologica|November 14, 2024
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centersViktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 9, 2025
NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, et al.
Blood Advances|August 27, 2024
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional seriesNarendranath Epperla, Adam S Zayac, Daniel J Landsburg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021Andrew D Zelenetz, Leo I Gordon, Julie E Chang, et al.
Blood|February 12, 2025
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphomaLaura Samples, Hossein Sadrzadeh, Matthew J Frigault, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2023
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Blood Advances|March 19, 2026
Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin LymphomaGrace Baek, Gaurav Varma, Samuel Yamshon, et al.
British Journal of Haematology|December 22, 2018
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphomaBrian T Hill, Loretta Nastoupil, Allison M Winter, et al.
Frontiers in Oncology|May 19, 2023
A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trialsJeffrey R Whiteaker, Lei Zhao, Regine M Schoenherr, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, et al.
Haematologica|November 14, 2024
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centersViktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 9, 2025
NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, et al.
Blood Advances|August 27, 2024
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional seriesNarendranath Epperla, Adam S Zayac, Daniel J Landsburg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021Andrew D Zelenetz, Leo I Gordon, Julie E Chang, et al.
Blood|February 12, 2025
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphomaLaura Samples, Hossein Sadrzadeh, Matthew J Frigault, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2023
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, et al.
Pageof 16